Sangamo Biosciences reported $-0.33 in EPS Earnings Per Share for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Acceleron Pharma XLRN:US -1.05 0
Alnylam Pharmaceuticals ALNY:US $ -1.61 0.1
Amgen AMGN:US $ 4.38 0.68
Avrobio Inc AVRO:US -0.74 0.09
Bayer BAYN:GR € 1.61 0.98
Biocryst Pharmaceuticals BCRX:US -0.24 0.12
Biogen BIIB:US $ 5.68 0.34
Biomarin Pharmaceutical BMRN:US $ 0.07 0.02
Bluebird Bio BLUE:US $ -3.43 0.36
Five Prime Therapeutics FPRX:US -0.51 0
Gilead Sciences GILD:US $ 1.87 0.21
GlaxoSmithKline GSK:LN 0.28 0.05
Intercept Pharmaceuticals ICPT:US $ -0.33 0.89
IONIS PHARMACEUT IONS:US $ -0.57 0.07
Johnson & Johnson JNJ:US 2.48 0.11
Karyopharm Therapeutics KPTI:US -0.71 0.06
Merk MRK:US $ 1.31 0.09
Novartis NOVN:VX SF 1.66 0.14
Omeros OMER:US -0.46 0.11
Pfizer PFE:US $ 1.07 0.14
Regulus Therapeutics RGLS:US -0.08 0
Sangamo Biosciences SGMO:US $ -0.33 0.01
Sanofi SAN:FP € 1.38 0.23
Sarepta Therapeutics SRPT:US -2.3 0.2
Ultragenyx Pharmaceutical RARE:US $ -1.81 0.22
Vertex Pharmaceuticals VRTX:US $ 3.11 0.13
Ziopharm Oncology ZIOP:US -0.11 0.01